Concert Pharmaceuticals Inc (NASDAQ:CNCE) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John G. Freund Other companies: SI-BONE, Inc. (Director · Since at least Oct 16, 2018); Collegium Pharmaceutical, Inc. (Director · Since at least May 6, 2015); Sutro Biopharma, Inc. (Director · Sep 26, 2018 – Jun 6, 2024 · Past); Protara Therapeutics, Inc. (Director · Oct 21, 2014 – Nov 8, 2019 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Dec 10, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – May 29, 2007 · Past); Hansen Medical Inc (Director · Nov 15, 2006 – Jun 17, 2009 · Past); XenoPort Inc (Director · May 2, 2006 – Jul 5, 2016 · Past) | Director · Feb 12, 2014 – Feb 20, 2014 · Past |
| Wendall Wierenga Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Cytokinetics, Incorporated (Director · Since at least Feb 9, 2011); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); Santarus Inc (EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past); XenoPort Inc (Director · May 7, 2009 – Jul 5, 2016 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past) | Director · Mar 13, 2014 – Jun 14, 2018 · Past |
| Richard Aldrich Other companies: KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 3, 2018 · Past); PTC Therapeutics, Inc. (Director · Mar 7, 2013 – Jun 8, 2015 · Past); Tempest Therapeutics, Inc. (Director · Jun 11, 2012 – Dec 7, 2018 · Past); Verastem, Inc. (Director · Jan 26, 2012 – Jun 10, 2014 · Past) | Director · Feb 12, 2014 – Mar 6, 2023 · Past |
| James Cassella Other companies: Trevi Therapeutics, Inc. (Chief Development Officer · Since at least Feb 13, 2020); Alexza Pharmaceuticals Inc (Former EVP, R&D and CSO, Director · Mar 8, 2006 – Jan 23, 2015 · Past) | Chief Development Officer · Feb 2, 2015 – Mar 6, 2023 · Past |
| Wilfred E Jaeger Other companies: Neuronetics, Inc. (Director · Jun 27, 2018 – May 25, 2023 · Past); Nevro Corp (Director · Feb 27, 2018 – May 21, 2020 · Past) | Director · Jun 14, 2018 – Mar 6, 2023 · Past |
| D Ryan Daws Other companies: enGene Therapeutics Inc. (Chief Financial Officer · Since at least Nov 27, 2023) | Chief Financial Officer · Feb 12, 2014 – Jan 4, 2017 · Past |
| Helmut Schuhsler Other companies: Enanta Pharmaceuticals, Inc. (Director · Mar 20, 2013 – Feb 21, 2014 · Past) | Director · Feb 12, 2014 – Jun 11, 2015 · Past |
| Jeffrey A Munsie Other companies: Merrimack Pharmaceuticals Inc (General Counsel · Mar 31, 2017 – Dec 11, 2018 · Past) | Chief Legal Officer · Sep 23, 2019 – Mar 6, 2023 · Past |
| Nancy Stuart Other companies: KalVista Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2022) | Chief Operating Officer · Jan 6, 2023 – Mar 6, 2023 · Past |
| Roger D Tung Other companies: Decoy Therapeutics Inc. (Director · Oct 30, 2017 – Jul 25, 2018 · Past) | Chief Executive Officer, Director · Feb 12, 2014 – Mar 6, 2023 · Past |
| Ryan Lynch Other companies: Crescent Biopharma, Inc. (Senior Vice President, Finance and Chief Accounting Officer · Since at least Jun 13, 2025) | PAO · Jun 15, 2017 – Aug 15, 2019 · Past |
| Marc A Becker | Chief Financial Officer · Jan 4, 2018 – Mar 6, 2023 · Past |
| Peter Barton Hutt | Director · Jun 9, 2022 – Mar 6, 2023 · Past |
| Robert Silverman | Senior VP, General Counsel · Feb 12, 2014 – Mar 13, 2017 · Past |